Boston Scientific Corporation (ETR:BSX)

Market Cap	123.16B
Revenue (ttm)	16.18B
Net Income (ttm)	1.79B
Shares Out	n/a
EPS (ttm)	1.21
PE Ratio	68.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	460
Average Volume	233
Open	84.60
Previous Close	82.00
Day's Range	82.80 - 84.60
52-Week Range	62.00 - 105.00
Beta	n/a
RSI	36.83
Earnings Date	Apr 23, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: BSX

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD